Obe-cel achieves 100% complete remission rate in a cohort of indolent B Cell Non-Hodgkin lymphoma patients with excellent CAR T engraftment, expansion, and persistence
No ICANS or high grade Cytokine Release Syndrome observed
Durability of response in ALL patients continues to support potential for transformational therapy in adult ALL
Conference Call to be held on Friday, June 11, 2021 at 8:30 am ET / 1:30 pm BST
Conference Call
Management will host a conference call and webcast today at 8:30 am ET/1:30 pm BST to discuss the data presented at EHA. To listen to the webcast and view the accompanying slide presentation, please go to the events section of Autolus’ website.
The call may also be accessed by dialing (866) 679-5407 for U.S. and Canada callers or (409) 217-8320 for international callers. Please reference conference ID 3697562. After the conference call, a replay will be available for one week. To access the replay, please dial (855) 859-2056 for U.S. and Canada callers or (404) 537-3406 for international callers. Please reference conference ID 3697562.
https://finance.yahoo.com/news/autolus-therapeutics-presents-data-obe-110000390.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.